SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Artelo Biosciences to Showcase ART26.12 at IASP 2026 Congress

Artelo Biosciences says it will showcase its first-in-human FABP5 inhibitor ART26.12 at the IASP 2026 World Congress on Pain.

ARTL

Related stories